Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Major Shareholder Versant Venture Capital Vi, L. Sells 89,990 Shares

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) major shareholder Versant Venture Capital Vi, L. sold 89,990 shares of Monte Rosa Therapeutics stock in a transaction on Monday, October 28th. The stock was sold at an average price of $9.

By: ETF Daily News

Nov 17 2024
6
286 Views

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Major Shareholder Versant Venture Capital Vi, L. Sells 89,990 Shares

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) major shareholder Versant Venture Capital Vi, L. sold 89,990 shares of Monte Rosa Therapeutics stock in a transaction on Monday, October … [+5175 chars]

Related

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Major Shareholder Versant Venture Capital Vi, L. Sells 89,990 Shares

Exchange Traded Concepts LLC Has $158,000 Stock Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Head-To-Head Contrast

Most Important Things You Need To Do Right Now To Be Prepared For a Natural or Man-Made Disaster

Digital pharma platform

Zombie Caterpillar Fungus Could Be Used to Save Human Lives

RFK Jr. has been picked for HHS secretary. Here are the agencies he would oversee

3 Dividend Stocks To Consider With Up To 6.2% Yield

Grapefruit Oil Strategic Business Report 2024: Global Market to Reach $557.4 Million by 2030 - Surge in Adoption in Natural Fragrances and Perfumes Expands Opportunities

Valencia floods: How to prevent a natural disaster from becoming a public health crisis

InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm